We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Website5amventures.com
Phone650-233-8600
Employees
Founded2002
DescriptionVenture capital Firm

Funds

Total$668M
5AM Ventures III, 12/2009 $198M
5AM Ventures II, 1/2006 $150M
5AM Ventures I, 1/2002 $65M
5AM Co-Investors III, 12/2009 $2.12M
5AM Co-Investors III, 2/2010 $3.37M
5AM Ventures IV, L.P., 12/2013 $250M

Offices

Menlo Park, CA
2200 Sand Hill Road
Suite 110
Menlo Park, CA, 94025
USA
Waltham, MA
Waltham Woods Corporate Center
890 Winter Street, Suite 140
Waltham, MA, 02451
USA

People

Founder and Managing Partner
Founder & Managing Partner
Managing Partner
Partner
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Show All People

Tags

5AM Ventures

5AM Ventures is a seed and early-stage venture capital firm focused on building next-generation life science companies. Founded in 2002, 5AM Ventures has over $200 million under management and is actively investing its second fund. The firm has offices in Menlo Park, CA and Waltham, MA.

Recent Milestones

Investments

Company Date Round Size Participants
Epirus Biopharmaceuticals 4/2014Series B$36M7
RuiYi 3/2014Series B$15M6
scPharmaceuticals 3/2014Series A$16M2
Igenica 1/2014Series C$14M4
Biodesy 10/2013Series A$15M3
Arvinas 9/2013Series A$15M4
Audentes Therapeutics 7/2013Series A$30M3
Pearl Therapeutics 4/2013Private Equity$41.7M4
Novira Therapeutics 3/2013Series A$25M7
Achaogen 3/2013Private Equity$18.9M7
Ceterix Orthopaedics 1/2013Series B$19.5M3
Pearl Therapeutics 11/2012Series D$65M4
Relypsa 10/2012Venture Round$2.6M3
Kinestral Technologies 10/2012Venture Round$7M1
Pearl Therapeutics 10/2012Private Equity$23.3M4
Atterocor 8/2012Series A$16M3
Relypsa 7/2012Private Equity$62.4M7
Epirus Biopharmaceuticals 7/2012Venture Round$5M2
Igenica 6/2012Series C$33M4
Epirus Biopharmaceuticals 4/2012Venture Round$8.08M2
Viveve 4/2012Venture Round$7.21M1
Cleave Biosciences 10/2011Series A$44M6
Pulmatrix 8/2011Series B$14M4
DVS Sciences 7/2011Series A$14.6M3
Semprus BioSciences 12/2010Series B$18M5
Pearl Therapeutics 10/2010Series C$69M3
Synosia Therapeutics 10/2010Series C$30M7
Relypsa 9/2010Series B$70M6
Incline Therapeutics 6/2010Series A$43M6
Igenica 6/2010Series B$24M3
Achaogen 4/2010Series C$56M7
Pearl Therapeutics 3/2010Series C$15M3
Pulmatrix 11/2009Series B$30.2M4
Flexion Therapeutics 10/2009Series A$33M3
Anaphore 6/2009Series A$13M5
Ambrx 4/2009Series D$10M7
Pulmatrix 3/2009Series A$3.5M2
Rennovia 3/2009Series A$16.3M2
Synosia Therapeutics 1/2009Series B$29M7
KaloBios Pharmaceuticals 12/2008Series D$12M8
Semprus BioSciences 12/2008Series A$8M2
S*Bio 10/2008Venture Round$26M6
Pearl Therapeutics 7/2008Series A$18M4
Anaphore 4/2008Venture Round$8M2
PhaseRx 2/2008Series A$20.2M3
Anaphore 1/2008Venture Round$3.3M1
Relypsa 10/2007Series A$33M6
Marcadia Biotech 5/2007Series A$15M3
Synosia Therapeutics 1/2007Venture Round$32.5M4
Achaogen 10/2006Series B$26M5
Marcadia Biotech 3/2006Venture Round$1M2

Videos

Sources

  1. SEC (sec.gov) [edit]
  2. AltAssets (altassets.com) [edit]
  3. AltAssets (altassets.com) [edit]
  4. SEC D (sec.gov) [edit]
  5. SEC D/A (sec.gov) [edit]
  6. 5AM VENTURES RAISES $250 MILLION LIFE SCIENCE VENTURE CAPITAL FUND (5amventures.com) [edit]
  7. Epirus Biopharmaceuticals Closes $36M Series B Financing (finsmes.com) [edit]
  8. RuiYi Raises $15m Series B Financing (finsmes.com) [edit]
  9. scPharmaceuticals Closes $16.0M Series A Venture Financing (finsmes.com) [edit]
  10. Igenica Raises $14M in Series C Financing (finsmes.com) [edit]
  11. Biodesy Secures $15M in Series A Financing (finsmes.com) [edit]
  12. Arvinas Raises $15M Series A for Protein-Degrading Therapies (pevc.dowjones.com) [edit]
  13. Audentes Therapeutics Closes $30M Series A Financing (finsmes.com) [edit]
  14. VC Funding: Q2 2013 source [edit]
  15. Novira Therapeutics Completes $25 Million Series A Financing (noviratherapeutics.com) [edit]
  16. VC Funding - Q2 2013 [edit]
  17. Ceterix Orthopaedics Raises $19.5M in Series B Financing (finsmes.com) [edit]
  18. Pearl Therapeutics Raises $65M in Series D Financing (finsmes.com) [edit]
  19. VC funding: Q4 2012 [edit]
  20. VC funding: Q4 2012 [edit]
  21. VC funding: Q4 2012 [edit]
  22. Atterocor Raises $16M in Series A Funding (finsmes.com) [edit]
  23. VC Funding: Q3 2012 source [edit]
  24. VC Funding: Q3 2012 source [edit]
  25. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
  26. VC Funding: Q2 2012 source [edit]
  27. VC Funding: Q2 2012 source [edit]
  28. Cleave Biosciences Raises $42M in Series A Financing (finsmes.com) [edit]
  29. Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis (eon.businesswire.com) [edit]
  30. DVS Sciences Completes $14.6M Series A Financing (finsmes.com) [edit]
  31. SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION (semprusbio.com) [edit]
  32. Pearl lands $69M Series C for mid-stage COPD program (fiercebiotech.com) [edit]
  33. Synosia Therapeutics Raises $30M in Series C Financing (synosia.com) [edit]
  34. Relypsa Raises $70M in Series B Financing (finsmes.com) [edit]
  35. Incline Therapeutics, Inc.: Series A $43M (onbiovc.com) [edit]
  36. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
  37. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
  38. Pearl Therapeutics, Inc.: Series C $15M (onbiovc.com) [edit]
  39. Xconomy Boston (xconomy.com) [edit]
  40. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
  41. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
  42. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
  43. Mass High Tech (masshightech.com) [edit]
  44. SEC (sec.gov) [edit]
  45. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
  46. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
  47. Semrus BioSciences Raises $8 Million (us.ellre.com) [edit]
  48. Capital Report Index [edit]
  49. Pearl Therapeutics ups its first round funding (venturebeat.com) [edit]
  50. April 15, 2008 - Anaphore Receives $8M In Financing (anaphoreinc.com) [edit]
  51. Biotech Startup PhaseRx Wins $19M Pledge (biospace.com) [edit]
  52. 5AM Ventures puts $3.3M into stealthy immunology startup ImmunoNewco (venturebeat.com) [edit]
  53. Amgen, Relypsa and the art of the biotech-spinout-startup-restart (venturebeat.com) [edit]
  54. MARCADIA BIOTECH COMPLETES $15 MILLION SERIES A FINANCING (marcadiabiotech.com) [edit]
  55. Neurological co. Synosis raises $32.5M (venturebeat.com) [edit]
  56. Achaogen Closes Series B Financing (achaogen.com) [edit]
  57. EDGAR [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy